Achieve Life Sciences, Inc. Debt Instrument, Basis Spread on Variable Rate
Achieve Life Sciences, Inc. (ACHV) had Debt Instrument, Basis Spread on Variable Rate of 2.25% as of 2023-05-15, per its 10-Q filed 2024-05-09.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2024-05-09
- 2023-05-15: Debt Instrument, Basis Spread on Variable Rate 2.25%.
- 2021-12-22: Debt Instrument, Basis Spread on Variable Rate 2.25%.
| Period end | Debt Instrument, Basis Spread on Variable Rate |
|---|---|
| 2023-05-15 | 2.25% 10-Q · filed 2024-05-09 |
| 2021-12-22 | 2.25% 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |